Genic Co.,Ltd
KOSDAQ
₩26,150.00
+1.55%
Delayed · cached 15 min
Fair value analysis
123330
Genic Co.,Ltd
₩26,150.00
Close used for this calculation
₩38,301.45Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
67/100
Quality radar
Consensus fair value
₩38,301.45
Below FV▲ +46.5% against the close used
Model range ₩16,888.11 – ₩48,280.00
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩16,888.11Fair value₩38,301.45Bull₩48,280.00
FairClose
52-week traded range
52W low ₩22,750.0052W high ₩36,900.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Genic Co.,Ltd closed at ₩26,150.00, 31.7% below the consensus fair value of ₩38,301.45 drawn from 7 valuation models.
Financial DNA score 67/100 — Strong. P/E of 10.8x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩43,072.23
+64.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩16,888.11
-35.4%
√(22.5 × EPS × BVPS)
EPS=2414, BVPS=5251 · outside Graham range (P/E 10.8, P/B 5) — asset-light, treat as a rough floor
P/E Fair Value
₩48,280.00
+84.6%
EPS × 20x (sector P/E)
EPS=2414, Sector P/E=20x
EV/EBITDA
₩21,194.78
-18.9%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=16.58B
Book Value (P/B)
₩32,263.67
+23.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=5251, ROE=46%, g=3%, r=10%
Reverse DCF
₩26,150.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -1.2% | Historical: 0%
Margin of Safety
₩27,060.09
+3.5%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=36080.11, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.